SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-159075
Filing Date
2022-05-25
Accepted
2022-05-25 07:30:01
Documents
12
Period of Report
2022-05-24
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d306825d8k.htm   iXBRL 8-K 22996
  Complete submission text file 0001193125-22-159075.txt   147501

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vrca-20220524.xsd EX-101.SCH 2857
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20220524_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20220524_pre.xml EX-101.PRE 11708
6 EXTRACTED XBRL INSTANCE DOCUMENT d306825d8k_htm.xml XML 3443
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 22958881
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences